Dengue fever – Diagnostics – Overview of Information and Clinical Research

Dengue fever diagnostics involve a combination of clinical evaluation, travel history assessment, and specialized laboratory testing to accurately identify this mosquito-borne viral infection that affects millions of people worldwide each year.

Introduction: Who Should Undergo Diagnostics and When

Anyone who develops a fever along with flu-like symptoms after visiting or living in tropical and subtropical regions should consider seeking diagnostic testing for dengue fever. These regions include parts of Central and South America, Africa, Asia, the Pacific Islands, and some areas of the United States such as Puerto Rico, the U.S. Virgin Islands, Florida, Hawaii, Texas, Arizona, and California.^[1]^[2]

Dengue fever diagnostics are especially important for people who develop symptoms within two weeks after returning from areas where the disease is common. The symptoms typically appear between four and ten days after being bitten by an infected mosquito, though this window can range from three to fourteen days depending on the individual.^[3]^[4]

If you experience a sudden high fever reaching 104°F (40°C) combined with severe headache, pain behind the eyes, muscle and joint pain, nausea, vomiting, swollen glands, or a rash, it is advisable to see a healthcare provider promptly. When you visit the doctor, be sure to describe any recent international travel in detail, including the specific countries you visited and the dates of your trip, as well as any possible exposure to mosquitoes.^[10]^[2]

⚠️ Important

Immediate medical attention is necessary if you develop warning signs of severe dengue, which typically appear 24 to 48 hours after your fever goes away. These warning signs include severe abdominal pain, persistent vomiting (at least three times in 24 hours), bleeding from the nose or gums, vomiting blood, blood in stool, extreme tiredness or restlessness, or pale and cold skin. Severe dengue is a medical emergency that can lead to shock, respiratory distress, and even death if not treated promptly.

Children and elderly individuals are at higher risk for developing serious complications from dengue infection, making early diagnosis particularly crucial for these age groups. Additionally, people who have previously been infected with one type of dengue virus and then get infected with a different strain are at increased risk of developing severe dengue, a life-threatening condition also known as dengue hemorrhagic fever or dengue shock syndrome.^[2]^[5]

Diagnostic Methods

Diagnosing dengue fever can be challenging because its signs and symptoms closely resemble those of many other diseases, including malaria, chikungunya, Zika virus, influenza, typhoid fever, and leptospirosis. This similarity means that healthcare providers must rely on a combination of clinical assessment and laboratory confirmation to make an accurate diagnosis.^[10]^[5]

Clinical Evaluation and Travel History

The diagnostic process begins with a thorough clinical evaluation. Your doctor will ask detailed questions about your symptoms, when they started, and their severity. They will pay particular attention to the characteristic features of dengue, such as high fever, intense headache, severe pain behind the eyes (retro-ocular pain), and the distinctive muscle and joint pain that has earned dengue the nickname “breakbone fever.”^[6]

Travel history forms a critical part of the diagnostic assessment. Your healthcare provider needs to know whether you have recently traveled to or live in an area where dengue is endemic (meaning the disease is constantly present in that geographic area). They will want to know the specific locations you visited, the duration of your stay, and whether you experienced mosquito bites during that time. This information helps narrow down the likelihood of dengue infection versus other possible causes of your symptoms.^[10]^[4]

Laboratory Testing

Blood tests are essential for confirming a dengue diagnosis. Laboratory-based and point-of-care diagnostics are critical tools for controlling and managing dengue, though there are significant global differences in laboratory capabilities that can present challenges in some regions.^[3]^[11]

There are several types of blood tests used to detect dengue infection. The choice of test depends on how long you have been experiencing symptoms, as different tests work better at different stages of the illness. Diagnosis usually involves identifying virus antigens (substances that trigger an immune response) using diverse laboratory techniques.^[6]

One common test is the NS1 antigen test, which can detect a specific protein produced by the dengue virus early in the infection. This test is particularly useful during the first few days of illness when the virus is actively replicating in the body. Another approach is polymerase chain reaction (PCR) testing, which looks for the genetic material (RNA) of the dengue virus itself. PCR is highly sensitive and can identify which of the four dengue virus types is causing the infection.^[5]^[12]

For infections that have been present for a longer time, antibody tests become more useful. These tests look for IgM antibodies and IgG antibodies that your immune system produces in response to the dengue virus. IgM antibodies appear first, typically within a few days after symptoms start, while IgG antibodies develop later and can indicate either a current infection or past exposure to dengue.^[5]

Additional Monitoring Tests

Beyond confirming the presence of dengue virus, healthcare providers often order additional blood tests to monitor your condition and watch for signs of severe dengue. These include tests to measure your platelet count (the number of clot-forming cells in your blood) and your hematocrit level (the proportion of red blood cells in your blood).^[12]

If you have confirmed or suspected dengue fever, your doctor may recommend that you have your platelet count and hematocrit measured daily starting from the third day of illness until one to two days after your fever goes away. When dengue progresses to its severe form, blood vessels can become damaged and leaky, causing platelets to drop and hematocrit to rise as blood becomes more concentrated. Monitoring these values helps doctors identify patients who are developing complications and need closer observation or hospital admission.^[15]

Clinical signs of dehydration also guide the need for diagnostic monitoring. If you develop symptoms such as rapid heartbeat (tachycardia), prolonged time for skin color to return after being pressed (prolonged capillary refill time), cool or blotchy skin, weakened pulse, changes in mental status, decreased urine output, rising hematocrit, narrowed difference between systolic and diastolic blood pressure readings (narrowed pulse pressure), or low blood pressure (hypotension), your doctor will likely want more frequent testing and possibly hospital admission for intravenous fluid administration.^[15]

Distinguishing Dengue from Other Diseases

Because dengue symptoms overlap significantly with other tropical diseases and common viral infections, doctors must carefully consider other possible diagnoses. The presence of a skin rash, which often appears a few days after the fever starts, can help distinguish dengue from some other conditions. The rash in dengue typically looks like small red spots and may be accompanied by itching.^[1]^[5]

In areas where multiple mosquito-borne diseases occur, doctors may need to test for several conditions simultaneously. For example, the Aedes mosquitoes that transmit dengue can also spread Zika virus and chikungunya virus. Malaria, which is transmitted by different mosquito species, produces similar fever patterns and must be ruled out in regions where both diseases exist.^[10]

Diagnostics for Clinical Trial Qualification

While the provided sources contain extensive information about dengue fever symptoms, transmission, and general diagnostic methods, they do not include specific details about diagnostic tests or criteria used to qualify patients for enrollment in clinical trials. Clinical trial protocols typically require confirmed laboratory diagnosis of dengue infection, but the exact testing methods and eligibility criteria vary depending on the specific research study and its objectives.

Prognosis and Survival Rate

Prognosis

The outlook for people with dengue fever is generally favorable, with most individuals recovering completely within one to two weeks. The majority of dengue infections cause either no symptoms at all or only mild illness that can be managed with supportive care at home. Research estimates suggest that nearly 400 million people get infected with dengue each year, but approximately 80% experience no symptoms whatsoever.^[2]^[3]

For those who do develop symptoms, the typical course of illness lasts between two and seven days. Most patients recover fully after about a week, though some may experience lingering fatigue for several weeks after the acute illness has resolved. Recovery generally takes place at home with rest, adequate fluid intake, and medication to control fever and pain.^[3]^[11]

However, the prognosis becomes more serious for the small proportion of patients who develop severe dengue. About 1 in 20 people who get sick with dengue will progress to severe dengue, also known as dengue hemorrhagic fever or dengue shock syndrome. This life-threatening complication typically occurs when someone who was previously infected with one type of dengue virus gets infected again with a different strain. The risk of severe dengue is particularly elevated in children, elderly individuals, and those experiencing a second infection with a different dengue virus type.^[2]^[12]

Several factors influence the prognosis for dengue patients. Previous infection with any dengue virus strain can increase the risk of developing severe disease upon subsequent infection with a different type, a phenomenon related to antibody-dependent enhancement. Other risk factors for poor outcomes include very young or advanced age, presence of other chronic health conditions, delayed medical care, and inadequate fluid replacement during the critical phase of illness.^[5]

Early detection and proper medical care significantly improve outcomes for those who develop severe dengue. Access to appropriate supportive treatment, including careful fluid management and monitoring for complications, greatly lowers the risk of death from severe dengue. When patients with warning signs of severe disease receive timely hospital care, the prognosis improves substantially.^[3]^[11]

Survival rate

With proper medical management, the survival rate for dengue fever is quite high. Dengue poses a significant public health challenge globally, with over 100 million cases occurring annually and approximately 20,000 to 25,000 deaths reported each year. This means that the vast majority of people infected with dengue virus survive the illness.^[6]^[14]

For patients with uncomplicated dengue fever who receive appropriate supportive care, the survival rate approaches 100%. Deaths from dengue are rare when patients have access to proper medical attention and follow treatment recommendations for maintaining hydration and monitoring for warning signs of severe disease.^[3]

The fatality rate increases significantly for those who develop severe dengue without receiving timely medical intervention. However, when severe dengue is recognized early and patients receive proper hospital care with careful fluid management and treatment of hemorrhagic complications, the fatality rate can be reduced dramatically. Early access to proper medical care is the key factor that greatly lowers fatality rates of severe dengue.^[3]^[11]

In regions with well-established dengue treatment protocols and adequate healthcare infrastructure, survival rates for even severe dengue are considerably better than in areas with limited medical resources. The ability to provide supportive hospital care, including intravenous fluids, blood pressure monitoring, and blood transfusions when needed, makes a substantial difference in patient outcomes.^[10]

#1 Clinical Trials Search in Europe